These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28620006)

  • 1. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
    Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
    Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.
    Frühwald MC; Nemes K; Boztug H; Cornips MCA; Evans DG; Farah R; Glentis S; Jorgensen M; Katsibardi K; Hirsch S; Jahnukainen K; Kventsel I; Kerl K; Kratz CP; Pajtler KW; Kordes U; Ridola V; Stutz E; Bourdeaut F
    Fam Cancer; 2021 Oct; 20(4):305-316. PubMed ID: 33532948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
    Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
    Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
    Le Quang M; Ranchère-Vince D; Le Loarer F
    Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BRG1 (
    Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
    Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
    Fukushima H; Yamasaki K; Sakaida M; Tsujio N; Okuno T; Ishii N; Okada K; Fujisaki H; Matsusaka Y; Sakamoto H; Yoneda A; Hara J; Inoue T
    Pathol Int; 2021 Feb; 71(2):155-160. PubMed ID: 33378586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.
    Hasselblatt M; Thomas C; Federico A; Nemes K; Johann PD; Bison B; Bens S; Dahlum S; Kordes U; Redlich A; Lessel L; Pajtler KW; Mawrin C; Schüller U; Nolte K; Kramm CM; Hinz F; Sahm F; Giannini C; Penkert J; Kratz CP; Pfister SM; Siebert R; Paulus W; Kool M; Frühwald MC
    Am J Surg Pathol; 2022 Sep; 46(9):1277-1283. PubMed ID: 35446794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.
    Schneppenheim R; Frühwald MC; Gesk S; Hasselblatt M; Jeibmann A; Kordes U; Kreuz M; Leuschner I; Martin Subero JI; Obser T; Oyen F; Vater I; Siebert R
    Am J Hum Genet; 2010 Feb; 86(2):279-84. PubMed ID: 20137775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
    Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
    J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
    Bookhout C; Bouldin TW; Ellison DW
    Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
    Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
    J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
    Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
    Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.
    Shirai R; Osumi T; Terashima K; Kiyotani C; Uchiyama M; Tsujimoto S; Yoshida M; Yoshida K; Uchiyama T; Tomizawa D; Shioda Y; Sekiguchi M; Watanabe K; Keino D; Ueno-Yokohata H; Ohki K; Takita J; Ito S; Deguchi T; Kiyokawa N; Ogiwara H; Hishiki T; Ogawa S; Okita H; Matsumoto K; Yoshioka T; Kato M
    Eur J Hum Genet; 2020 Aug; 28(8):1124-1128. PubMed ID: 32218533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
    Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
    Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary SWI/SNF complex deficiency syndromes.
    Agaimy A; Foulkes WD
    Semin Diagn Pathol; 2018 May; 35(3):193-198. PubMed ID: 29397238
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.